Hi Reg EBITDA is harder to project and on the valuation side possibly less relevant than sales for this type of Co in the growth phase. Any ideas around revenue multiples? Cheers Nach
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025